多模式风湿复合治疗在儿童和青少年时期的影响
Katharina Kreilinger1, Regina Huehn1, Jessica I Hoell1
1Department of Pediatrics I, University Hospital, Martin-Luther-University Halle-Wittenberg, 06108 Halle (Saale), Germany.
Children (Basel, Switzerland)
|May 1, 2025
概括
多式风湿复合治疗 (MRCT) 显著改善了儿童和青少年的健康结果. 这种密集治疗可以减少炎症,疼痛和残疾,同时增强关节的移动性和整体健康.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 复杂的治疗方式.
- 儿童和青少年健康 儿童和青少年健康
背景情况:
- 多模式风湿复合治疗 (MRCT) 涉及密集的,高频率的程序 (≥11小时/周).
- 研究MRCT在儿科和青少年类风湿病的疗效对于优化护理至关重要.
研究的目的:
- 评估MRCT对儿科患者炎症标志物,功能,疼痛和关节移动性的影响.
- 评估MRCT对患有风湿性疾病的年轻人的主观幸福感和应对机制的影响.
主要方法:
- 在2009-2022年间对95名儿童进行的133个MRCT的回顾性分析.
- 评估包括炎症标志物 (CRP,ESR),儿童健康评估问卷 (CHAQ),疼痛强度,健康状况和关节运动.
- 统计分析使用t测试进行治疗前和治疗后的比较.
主要成果:
- 观察到C-反应蛋白 (CRP) 和红细胞沉率 (ESR) 的显著降低.
- 患者报告疼痛强度降低,健康状况改善,更好地应对疾病.
- 童年健康评估问卷 (CHAQ) 的残疾指数适度下降,并改善了关节的移动性.
- 在同时出现体形疾病的患者中也注意到了积极的结果.
结论:
- 在儿童类风湿病患者中,MRCT对主观福祉和身体健康都有显著的积极影响.
- 治疗建议儿童和青少年,包括那些有额外的体形疾病.
- MRCT为改善复杂类风湿病症的年轻患者的生活质量提供了可行的治疗选择.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
108
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
108
01:29Autoimmune Disorders
328
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
328
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
91
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
91
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103
01:29Inflammatory Bowel Disease IV: Pharmacological Management
82
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
82